Compare Novavax Inc (NVAX) vs Sprott Uranium Miners ETF (URNM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Sprott Uranium Miners ETF — how do they compare? Novavax Inc trades at $8.08 (market cap $1.30B), while Sprott Uranium Miners ETF trades at $50.32. The key difference: Novavax Inc is trading nearer its 52-week high, Sprott Uranium Miners ETF nearer its low. Which is the better fit depends on your goals.
| NVAX | URNM | |
|---|---|---|
Market Cap | $1.30B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $11.19 | $83.99 |
52-Week Low | $6.22 | $44.14 |
Enterprise Value | $800.50M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Sprott Uranium Miners ETF
URNM is a pure-play ETF that invests in the global uranium industry. It provides exposure to companies involved in the mining, exploration, and production of uranium, as well as physical uranium holdings, with top assets like Cameco, Uranium Energy Corp, and the Sprott Physical Uranium Trust.
Read more on URNM →
